Company Description
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel.
The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days.
It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics.
In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services.
G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.
| Country | Israel |
| Founded | 2014 |
| IPO Date | Jun 25, 2021 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 84 |
Contact Details
Address: 5 Oppenheimer St. Rehovot, L3 7670105 Israel | |
| Phone | 972-89584777 |
Stock Details
| Ticker Symbol | GMVDF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001760764 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yacov Geva | Chief Executive Officer, President and Executive Director |
| Kobi Ben Efraim | Chief Financial Officer and Controller |
| Benny Tal | Vice President of Research & Development Corporate and Chief Technology Officer Corporate |
| Oded Shahar | Senior Vice President of Mergers and Acquisitions Corporate |
| Dror Nuriel-Roth | Executive Vice President of US Operations |
| Brett Tucker | Company Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 12, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Feb 7, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Dec 18, 2023 | 6-K | Report of foreign issuer |
| Nov 29, 2023 | 6-K | Report of foreign issuer |
| Oct 25, 2023 | D | Notice of Exempt Offering of Securities |
| Oct 24, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Oct 12, 2023 | 25-NSE | Filing |
| Oct 10, 2023 | 6-K | Report of foreign issuer |
| Sep 22, 2023 | 6-K | Report of foreign issuer |
| Sep 13, 2023 | 6-K | Report of foreign issuer |